These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2476625)

  • 21. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
    Heuer H; Gülker H; Hasfeld M; Frenking B; Behrenbeck T
    Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies with the enantiomers of the glycol metabolite of propranolol and their effects on the cardiac beta-adrenoceptor.
    Ogg GD; Neilson DG; Stevenson IH; Lyles GA
    J Pharm Pharmacol; 1987 May; 39(5):378-83. PubMed ID: 2886586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diprafenone.
    Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction.
    Thale J; Gülker H; Hindricks G; Haverkamp W; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():107-15. PubMed ID: 3678251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
    Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W
    Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo examination of beta-adrenoceptor characteristics after propranolol withdrawal.
    Chess-Williams RG; Broadley KJ
    J Cardiovasc Pharmacol; 1984; 6(4):701-6. PubMed ID: 6206329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
    Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N
    Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An approach to analysis of radiolabeled ligand interactions with specific receptors.
    Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
    Eur J Pharmacol; 1999 Dec; 386(2-3):279-88. PubMed ID: 10618480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
    Boucher M; Chassaing C; Hamel JD; Poirier JM
    Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias].
    Ishii M; Komori S; Satoh H; Ohta T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):259-66. PubMed ID: 6149986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External transport of beta-adrenergic binding sites in ischemic myocardium.
    Drímal J; Knezl V; Magna D; Strízová K
    Gen Physiol Biophys; 1987 Dec; 6(6):583-91. PubMed ID: 2895037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.
    Takenaka T; Asano M; Berdeaux A; Giudicelli JF
    Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ricin depresses cardiac function in the rabbit heart.
    Ma L; Hsu CH; Patterson E; Thadani U; Robinson CP
    Toxicol Appl Pharmacol; 1996 May; 138(1):72-6. PubMed ID: 8658515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
    Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
    J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of (-)-[3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes.
    Meurs H; van den Bogaard W; Kauffman HF; Bruynzeel PL
    Eur J Pharmacol; 1982 Nov; 85(2):185-94. PubMed ID: 6295780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.